Category: Featured Content
-
Harborside (HBOR.C) upgrades California grow-op, launches clone sales, pushes rev. projections higher
The company’s in-house brand, Harborside Farms will begin sales of clones grown at its Salinas facility at all Harborside branded locations, including Desert Hot Springs.
-
FansUnite (FANS.C) shareholders have head-on-a swivel as McBookie revenues surge
Betting volume was $2.2-million, an increase of 188%, compared with October, 2019.
-
(ATHA.Q), (BIIB.Q), (SAVA.Q), (DRAD.Q), (SUPN.Q), (XLV.NYSE): Trump or Biden? Canadians freak out, healthcare stocks go ballistic
Sick democracy – sick people – big profits. That was a cogitative jump that most investors seemed to make.
-
Xphyto (XPHY.C) targets industrial manufacture of psilocybin as U.S. voters weigh in on mushrooms
Today’s federal election results could change the regulatory landscape in Oregon and Washington DC, as the residents of those states will vote to decide if psilocybin should be decriminalised.
-
Freeport (FRI.V) targets porphyry-style gold and copper along the prolific PNG Orogenic Belt, Papua New Guinea
When one thinks of Papua New Guinea, one might evoke images of deep impenetrable jungles, wild-eyed Crazy’s that want your head on a stick, and big-ass bugs that can kill your ass. The fact is, Papua New Guinea is one of the most diverse countries on the planet, boasting over 850 different languages and roughly…
-
Manganese X (MN.V) develops HVAC virus air-scrubber, and advances Battery Hill manganese project
“We are diligently assembling all the moving pieces in our air quality management solution as current global circumstances call for hyper action in this regard,” stated Martin Kepman, CEO Manganese X, “Breathing virus free air in a contained environment has taken on greater meaning.”
-
Aequus (AQS.V) gains a new medical device licence for $90 million Canadian Dry Eye Disease market
Currently in Canada, the dry eye market is estimated at over $9O million, which includes both prescription and over-the-counter products.